Riskpilot← Back to searchSign inGet full accessMedioNova AB
ABActiveOrg 5592509169Neptunigatan 1Wholesale of other food · NACE 4638Est. 20200 employees
Revenue 2025
SEK 665K
+18% vs 2024
EBITDA margin
9.4%
+24% vs 2024
Equity ratio
57.1%
Financial strength
Net profit 2025
SEK 49K
+23% vs 2024
| Revenue | SEK 665K | +18% |
| EBITDA | SEK 63K | +24% |
| Net profit | SEK 49K | +23% |
| Total assets | SEK 504K | +66% |
| Equity | SEK 288K | +52% |
| Employees | 0 | — |
Legal name
MedioNova AB
Org number
5592509169
Legal form
Aktiebolag
NACE code
4638 · Wholesale of other food
Founded
2 april 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Marknadsföra och sälja hälsorelaterade produkter såsom kosttillskott, livsmedel och hygienprodukter i huvudsak relaterade till munhälsa och därmed förenlig verksamhet.
Address
Neptunigatan 1
Phone
+46406745199
Email
finance@medionova.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 557 | 1 078 | 660 | 563 | 665 |
| Staff expenses | — | −304 | −24 | −12 | −272 |
| EBITDA | 6 | 14 | 105 | 50 | 63 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 6 | 14 | 105 | 50 | 63 |
| Net financials | — | — | −0 | −0 | −1 |
| Profit before tax | 6 | 14 | 105 | 50 | 62 |
| Tax | −1 | −3 | −26 | −10 | −13 |
| Net profit | 5 | 11 | 79 | 40 | 49 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 203 | 361 | 416 | 303 | 504 |
| Equity | 130 | 140 | 219 | 189 | 288 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 73 | 220 | 197 | 114 | 216 |
| Total debt | 73 | 220 | 197 | 114 | 216 |
EBITDA margin
9.4%
This company
15.8%
Market median
-41% vs market
20212025
Equity ratio
57.1%
This company
38.2%
Market median
+49% vs market
20212025
Return on equity
17.0%
This company
18.4%
Market median
+8% vs market
20212025
Net profit margin
7.4%
This company
8.1%
Market median
-9% vs market
20212025
Asset turnover
1.32×
This company
1.12×
Market median
+18% vs market
20212025
Debt / equity
0.75×
This company
0.62×
Market median
+21% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CE Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedioNova AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Emil Christer Rexman | Chief Executive Officer | 0 companies |
| Oscar Christoffer Lindbom | Board of Directors | 0 companies |